DE1215719B - Verfahren zur Herstellung einer Molekuelverbindung des Coffeins - Google Patents

Verfahren zur Herstellung einer Molekuelverbindung des Coffeins

Info

Publication number
DE1215719B
DE1215719B DEA42386A DEA0042386A DE1215719B DE 1215719 B DE1215719 B DE 1215719B DE A42386 A DEA42386 A DE A42386A DE A0042386 A DEA0042386 A DE A0042386A DE 1215719 B DE1215719 B DE 1215719B
Authority
DE
Germany
Prior art keywords
caffeine
effect
molecular compound
production
french
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEA42386A
Other languages
German (de)
English (en)
Inventor
Med Yves Louis Rene Barre Dr
Jean Louis Molle
Maurice Gustave Eugen Vigneron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adisseo France SAS
Original Assignee
AEC Societe de Chimie Organique and Biologique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AEC Societe de Chimie Organique and Biologique SA filed Critical AEC Societe de Chimie Organique and Biologique SA
Publication of DE1215719B publication Critical patent/DE1215719B/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
DEA42386A 1962-02-22 1963-02-21 Verfahren zur Herstellung einer Molekuelverbindung des Coffeins Pending DE1215719B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR888884A FR1759M (OSRAM) 1962-02-22 1962-02-22

Publications (1)

Publication Number Publication Date
DE1215719B true DE1215719B (de) 1966-05-05

Family

ID=8773273

Family Applications (1)

Application Number Title Priority Date Filing Date
DEA42386A Pending DE1215719B (de) 1962-02-22 1963-02-21 Verfahren zur Herstellung einer Molekuelverbindung des Coffeins

Country Status (8)

Country Link
US (1) US3247203A (OSRAM)
BE (1) BE628521A (OSRAM)
CH (1) CH408946A (OSRAM)
DE (1) DE1215719B (OSRAM)
DK (1) DK119981B (OSRAM)
ES (1) ES285353A1 (OSRAM)
FR (1) FR1759M (OSRAM)
GB (1) GB991306A (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406903A (en) * 1981-01-21 1983-09-27 John Wyeth And Brother Limited Xanthine derivatives useful as antidepressives
WO2005102321A1 (ja) * 2004-04-19 2005-11-03 Kirin Beer Kabushiki Kaisha 糖新生によりアルコール代謝を促進又は疲労を改善する組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE694822C (de) * 1937-11-25 1940-08-08 Byk Guldenwerke Chem Fab Akt G Verfahren zur Herstellung wasserloeslicher Doppelverbindungen von Purinen
FR1216136A (fr) * 1959-01-30 1960-04-22 Cherifienne D Etudes Et De Rec Procédé de solubilisation de certaines bases puriques et pyrimidiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL84498C (OSRAM) * 1936-10-28
US2185219A (en) * 1937-04-13 1940-01-02 Smith Kline French Lab Furfuryl n-morpholine alkyl halide medicinal preparation
US2700667A (en) * 1952-01-03 1955-01-25 Bristol Lab Inc 8-(2-benzyl-4-chlorophenoxy) caffeine
US2688618A (en) * 1952-01-03 1954-09-07 Bristol Lab Inc Basic caffeine derivatives
GB790557A (en) * 1955-05-09 1958-02-12 Ward Blenkinsop & Co Ltd Piperazine derivatives
US2961377A (en) * 1957-08-05 1960-11-22 Us Vitamin Pharm Corp Oral anti-diabetic compositions and methods
US3094537A (en) * 1961-05-01 1963-06-18 Dow Chemical Co Resolution of acetyl-di-tryptophan

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE694822C (de) * 1937-11-25 1940-08-08 Byk Guldenwerke Chem Fab Akt G Verfahren zur Herstellung wasserloeslicher Doppelverbindungen von Purinen
FR1216136A (fr) * 1959-01-30 1960-04-22 Cherifienne D Etudes Et De Rec Procédé de solubilisation de certaines bases puriques et pyrimidiques

Also Published As

Publication number Publication date
DK119981B (da) 1971-03-22
US3247203A (en) 1966-04-19
BE628521A (OSRAM) 1963-05-29
GB991306A (en) 1965-05-05
FR1759M (OSRAM) 1963-05-03
ES285353A1 (es) 1963-08-01
CH408946A (fr) 1966-03-15

Similar Documents

Publication Publication Date Title
DE2167157C2 (de) 4-Substituierte-2-halogen-6,7,8-trimethoxychinazoline
DE2543184C2 (OSRAM)
DE1695346C3 (de) Glutarimidderivate und Verfahren zu ihrer Herstellung
DE2154245C3 (de) 3-Hydrazino-6-(2-hydroxypropylamino)-pyridazinderivate, Verfahren zu ihrer Herstellung und sie enthaltendes pharmazeutisches Präparat
DE1695756B2 (de) 3,1-benzoxazin-2-one, verfahren zu deren herstellung und arzneimittel
DE2403122C2 (OSRAM)
DE2221758C2 (de) Yohimbinderivat, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
DE1215719B (de) Verfahren zur Herstellung einer Molekuelverbindung des Coffeins
DE2028880C3 (de) N-Phenylcarbamoyl-3-(ßphenylisopropyl)sydnonunin, Verfahren zu dessen Herstellung und Arzneimittel
DE2458638A1 (de) Propiophenonderivate und deren herstellung
DE69007422T2 (de) 1-(4-Aminophenyl)-2-piperidinopropanon-Derivate, Verfahren zu deren Herstellung und therapeutische Verwendung.
DE2166270C3 (de) Nicotinoylaminoäthansulfonyl-2amino-thiazol
DE1792764C3 (de) Coronarmittel
DE2835043A1 (de) Bromhexin-derivate mit gegenueber bromhexin geringerer schleimloesender und hustenlindernder wirkung und geringerer toxizitaet
DE2655130B2 (de) Eine praktisch lösungsmittelfreie Kristallform des Cefacetril-Natriumsalzes
DE170302C (OSRAM)
DE2164847C3 (de) l-(2-Hydroxybutoxy)-3-hydroxybutan und Verfahren zu seiner Herstellung
DE2739659C3 (de) N-2,6-Dichlorphenyl-2-aminopyrimidin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
AT263801B (de) Verfahren zur Herstellung des neuen Lactons des 2-Allyl-2-(β-oxypropyl)-malonsäureureids
DE2164997C3 (de) 2-(2-Hydroxybutoxy)-3-hydroxybutan und Verfahren zu seiner Herstellung
DE2460041A1 (de) Pharmazeutisches mittel mit cerebralvasodilatatorischer wirkung
DE2241076B2 (de) Tetracyclinkomplex und dessen Salze, Verfahren zu dessen Herstellung und diesen Komplex enthaltende pharmazeutische Zusammensetzungen
DE2210382C2 (de) 10-(ω-[N-Diazabicyclo-alkyl]-acyl)-phenothiazine, ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneimittel
DE1303930C2 (de) 2-(2-chlor-4-methyl- oder-aethyl- anilino)-1,3- diazacyclopenten-(2), deren salze sowie ein verfahren zu deren herstellung
DE2156056C3 (de) 3-tf',2'-Diphenyläthyl)-5-(2piperidino-äthyl)-1,2,4-oxadiazol-4-hydroxybenzoyl-benzoat-(2), dessen Herstellung und diese Verbindungen enthaltende Präparate